-
Andrewes C H, Elford W J. Observations on anti-phage sera. I. 'The percentage law'[J]. Br J Exp Pathol, 1933, 14(): 367-376.
-
Ansarah-Sobrinho C, Nelson S, Jost C A. Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation[J]. Virology, 2008, 381(1): 67-74. doi: 10.1016/j.virol.2008.08.021
-
Brinton M A. The molecular biology of West Nile Virus: a new invader of the western hemisphere[J]. Annu Rev Microbiol, 2002, 56(): 371-402. doi: 10.1146/annurev.micro.56.012302.160654
-
Burke D S, Monath T P. 2001. Flaviviruses. In: Fields Virology (Knipe D M, Howley P M, Griffin D E, et al. eds), Philadelphia, PA: Lippincott, Williams, & Wilkins, p1043-1126.
-
Chambers T J, Hahn C S, Galler R. Flavivirus genome organization, expression, and replication[J]. Annu Rev Microbiol, 1990, 44(): 649-688. doi: 10.1146/annurev.mi.44.100190.003245
-
Colombage G, Hall R, Pavy M. DNA-based and alphavirus-vectored immunization with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus[J]. Virology, 1998, 250(1): 151-163. doi: 10.1006/viro.1998.9357
-
Deas T S, Binduga-Gajewska I, Tilgner M. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication[J]. J Virol, 2005, 79(8): 4599-4609. doi: 10.1128/JVI.79.8.4599-4609.2005
-
Falconar A K. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies:Design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins[J]. Arch Virol, 1999, 144(12): 2313-2330. doi: 10.1007/s007050050646
-
Gubler D, Kuno G, Markoff L. 2007. Flaviviruses. In: Fields virology (Knipe D M, Howley P M. ed. ), 5th ed. , Philadelphia, PA: Lippincott, Williams, & Wilkins, . vol. 1, p1153-1253.
-
Johnson A J, Martin D A, Karabatsos N. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay[J]. J Clin Microbiol, 2000, 38(5): 1827-1831.
-
Jones C, Patkar C, Kuhn R. Construction and applications of yellow fever virus replicons[J]. Virology, 2005, 331(2): 247-259. doi: 10.1016/j.virol.2004.10.034
-
Klasse P J, Sattentau Q J. Mechanisms of virus neutralization by antibody[J]. Curr Top Microbiol Immunol, 2001, 260(): 87-108.
-
Kummerer B M, Rice C M. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles[J]. J Virol, 2002, 76(10): 4773-4784. doi: 10.1128/JVI.76.10.4773-4784.2002
-
Lindenbach B D, Rice C M. 2007. Flaviviridae: the virus 17 and their replication. In: Fields virology (Knipe D M, Howley P M, . Griffin D E, et al. ed. ), 4th ed. , Philadelphia, PA: Lippincott, Williams, & Wilkins, p991-1042.
-
Liu W J, Chen H B, Khromykh A A. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication[J]. J Virol, 2003, 77(14): 7804-7813. doi: 10.1128/JVI.77.14.7804-7813.2003
-
Liu W, Wang X J, Mokhonov V V. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins[J]. J Virol, 2005, 79(3): 1934-1942. doi: 10.1128/JVI.79.3.1934-1942.2005
-
Martin D A, Biggerstaff B J, Allen B. Use of Immunoglobulin M Cross-Reactions in Differential Diagnosis of Human Flaviviral Encephalitis Infections in the United States[J]. Clin Diag Lab Immunol, 2002, 9(3): 544-549.
-
Martin D A, Muth D A, Brown T. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections[J]. J Clin Microbiol, 2000, 38(5): 1823-1826.
-
Mehlhop E, Ansarah-Sobrinho C, Johnson S. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclassspecific manner[J]. Cell Host Microbe, 2007, 2(6): 417-426. doi: 10.1016/j.chom.2007.09.015
-
Munoz-Jordan J L, Sanchez-Burgos G G, Laurent-Rolle M. Inhibition of interferon signaling by dengue virus[J]. Proc Natl Acad Sci USA, 2003, 100(24): 14333-14338. doi: 10.1073/pnas.2335168100
-
Pierson T C, Sanchez M D, Puffer B A. A rapid and quantitative assay for measuring antibody-mediated 18 neutralization of West Nile virus infection[J]. Virology, 2006, 346(1): 53-65. doi: 10.1016/j.virol.2005.10.030
-
Pincus S, Mason P W, Konishi E. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis[J]. Virology, 1992, 187(1): 290-297. doi: 10.1016/0042-6822(92)90317-I
-
Puig-Basagoiti F, Tilgner M, Forshey B M. Triaryl Pyrazoline Compound Inhibits Flavivirus RNA Replication[J]. Antimicrob Agents Chemother, 2006, 50(4): 1320-1329. doi: 10.1128/AAC.50.4.1320-1329.2006
-
Puig-Basagoiti F, Deas T S, Ren P. High-throughput assays using luciferase-expressing replicon, virus-like particle, and full-length virus for West Nile virus drug discovery[J]. Antimicrob Agents Chemother, 2005, 49(12): 4980-4988. doi: 10.1128/AAC.49.12.4980-4988.2005
-
Shi P Y, Tilgner M, Lo M K. Construction and characterization of subgenomic replicons of New York strain of West Nile virus[J]. Virology, 2002, 296(2): 219-233. doi: 10.1006/viro.2002.1453
-
Tardei G, Ruta S, Chitu V. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infections[J]. J Clin Microbiol, 2000, 38(6): 2232-2239.
-
Vazquez S, Guzman M G, Guillen G. Immune response to synthetic peptides of dengue prM protein[J]. Vaccine, 2002, 20(13-14): 1823-1830. doi: 10.1016/S0264-410X(01)00515-1